Drawing for PANDEMIC RESPONSE SOLUTIONS PARTNERS IN PROTECTION

USPTO serial 79244657

PANDEMIC RESPONSE SOLUTIONS PARTNERS IN PROTECTION

Reviewed by CopyMark Law Group

Reg. 5946687Status 709
Filing date
Status date
Registration date
Dec 31, 2019
Examiner
FARRELL, ANNE M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PANDEMIC RESPONSE SOLUTIONS PARTNERS IN PROTECTION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nancy Sabarra

Nancy Sabarra Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd St., 17th Fl.New York, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical and biological reagents for scientific and non-medical purposes; cell cultures and cell culture media for laboratory, scientific and research use; chemical preparations for scientific and industrial purposesSECTION 71 - CANCELLED—
005Pharmaceutical preparations, namely, vaccines and antivirals; adjuvants for medical purposes; antigens for medical purposesSECTION 71 - CANCELLED—
035Providing business consulting and information services in relation to crisis management and pandemic preparedness; providing business information on pandemic preparedness via a websiteSECTION 71 - CANCELLED—
042Medical research services; scientific research for medical purposes; scientific investigations for medical purposes; design and development of medical technologySECTION 71 - CANCELLED—
044Medical services; medical information services concerning vaccines; providing medical information in the healthcare sector; providing medical information and consulting services in relation to crisis management and pandemic preparedness; providing medical information on pandemic preparedness via a websiteSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 17, 2026C71TCANCELLED SECTION 71—
Jan 3, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 31, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jan 5, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 14, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 20, 2020XXSSGENERIC MADRID TRANSACTION SENT TO IB—
May 20, 2020XXCRGENERIC MADRID TRANSACTION CREATED—
Mar 31, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 31, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 15, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 15, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 12, 2019GPNXNOTIFICATION PROCESSED BY IB—
Sep 25, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 25, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Sep 25, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 9, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 6, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Sep 6, 2019ALIEASSIGNED TO LIE—
Sep 6, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 6, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 6, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 30, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 30, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 30, 2019ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Mar 5, 2019GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Mar 5, 2019GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 5, 2019CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 8, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 7, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 7, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 21, 2018RFNTREFUSAL PROCESSED BY IB—
Dec 1, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 30, 2018RFRRREFUSAL PROCESSED BY MPU—
Nov 16, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 15, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 13, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 7, 2018DOCKASSIGNED TO EXAMINER—
Nov 7, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 1, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance